|
|
Group I SUV < 5 (n = 225) |
Group II 5 ≤ SUV ≤ 10 (n = 304) |
Group III SUV > 10 (n = 504) |
p-value |
| PET CT Stage: |
|
|
|
|
| I |
164 (73%) |
151 (50%) |
97 (19%) |
<0.0001 |
| II |
23 (10%) |
36 (12%) |
109 (22%) |
|
| III |
28 (12%) |
68 (22%) |
197 (39%) |
|
| IV |
10 (4%) |
49 (16%) |
101 (20%) |
|
| Mediastinal LN: |
|
|
|
|
| N1 N (%) |
34 (15.1%) |
80 (26.3%) |
217 (43.1%) |
<0.0001 |
| N2 N (%) |
29 (12.9%) |
89 (29.3%) |
224 (44.4%) |
<0.0001 |
| N3 N (%) |
11 (4.9%) |
23 (7.7%) |
63 (12.5%) |
0.0024 |
| Metastasis: |
|
|
|
|
| M (%) |
7 (3.1%) |
40 (13.2%) |
98 (19.4%) |
<0.0001 |